HELLS and erythroleukemia: An in-frame Lsh deletion in the putative catalytic domain is frequently identified in human leukemias [7], and transplantation of hematopoietic precursors from Lsh-/- mice produced abnormal hematopoiesis and elevated rates of erythroleukemia in recipients [14].